- Report
- July 2026
- 160 Pages
Global
From €3731EUR$4,150USD£3,199GBP
- Report
- July 2026
- 160 Pages
Global
From €3731EUR$4,150USD£3,199GBP
- Report
- April 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- April 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- April 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- April 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- April 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- April 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- February 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- January 2026
- 160 Pages
Global
From €2841EUR$3,160USD£2,436GBP
€3551EUR$3,950USD£3,045GBP
- Report
- January 2026
- 160 Pages
Global
From €2841EUR$3,160USD£2,436GBP
€3551EUR$3,950USD£3,045GBP
- Report
- November 2025
- 160 Pages
Global
From €2841EUR$3,160USD£2,436GBP
€3551EUR$3,950USD£3,045GBP
- Report
- November 2025
- 160 Pages
Global
From €2841EUR$3,160USD£2,436GBP
€3551EUR$3,950USD£3,045GBP
- Report
- October 2025
- 160 Pages
Global
From €2841EUR$3,160USD£2,436GBP
€3551EUR$3,950USD£3,045GBP
- Report
- October 2025
- 160 Pages
Global
From €2841EUR$3,160USD£2,436GBP
€3551EUR$3,950USD£3,045GBP
- Report
- February 2026
- 144 Pages
Global
From €3551EUR$3,950USD£3,045GBP
- Report
- January 2026
- 128 Pages
Global
From €3551EUR$3,950USD£3,045GBP
- Report
- August 2025
- 260 Pages
Global
From €4491EUR$4,995USD£3,850GBP
- Report
- November 2025
- 145 Pages
Global
From €3551EUR$3,950USD£3,045GBP
- Report
- February 2026
- 196 Pages
Global
From €4361EUR$4,850USD£3,738GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more